Back to FDA Applications sponsored by MERCK SHARP DOHME

FDA Drug Application 020762 by MERCK SHARP DOHME

Application Number020762
Application Type New Drug Application
Sponsor ApplicantMERCK SHARP DOHME
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New formulation
Therapeutic Potential Standard
Orphan Code 


  
Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP010/1/1997N24949000   http://www.accessdata.fda.gov/drugsatfda_docs/nda/pre96/020762_s000.pdf 3/3/2010
AP011/18/1998SE82916001   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/1998/20762s1ltr.pdf 11/18/1998
AP011/18/1998SE82917001   http://www.accessdata.fda.gov/drugsatfda_docs/nda/98/20762-S001_Nasonex.pdf 11/18/1998
AP06/11/1998SCM       
AP011/2/1998SCP       
AP012/2/1999SE1       
AP04/16/1999SCS       
AP08/25/2004SCF10100007   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20762s007ltr.pdf 8/31/2004
AP08/25/2004SCF10101007   http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20762s007lbl.pdf 8/31/2004
AP08/25/2004SCF19585007   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020762_S007_NASONEX_AQUEOUS_NASAL_SPRAY.pdf 4/2/2008
AP010/4/2000SCP       
AP012/1/2000SLR       
AP02/22/2001SCS       
AP07/17/2002SE52914011   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/20762se5011ltr.pdf 7/17/2002
AP07/17/2002SE52915011   http://www.accessdata.fda.gov/drugsatfda_docs/label/2002/20762s11lbl.pdf 7/17/2002
AP01/11/2002SCM       
AP09/13/2002SCS       
AP03/3/2003SLR4239014   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20762slr014ltr.pdf 3/10/2003
AP03/3/2003SLR17142014   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2003/020762_S014_NASONEX_AP.pdf 7/9/2007
AP012/18/2003SLR7353021   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/20762slr021ltr.pdf 12/23/2003
AP012/18/2003SLR7432021   http://www.accessdata.fda.gov/drugsatfda_docs/label/2003/20762slr021_nasonex_lbl.pdf 12/29/2003
AP012/15/2004SE110858023   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20762s023ltr.pdf 12/30/2004
AP012/15/2004SE110890023   http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/20762s023lbl.pdf 12/30/2004
AP012/15/2004SE135264023   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2004/020762Orig1s023_FINAL_corrected.pdf 2/27/2013
AP05/26/2010SE525655038   http://www.accessdata.fda.gov/drugsatfda_docs/label/2010/020762s038lbl.pdf 5/28/2010
AP05/26/2010SE525659038   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/020762s038ltr.pdf 6/2/2010
AP01/19/2011SE127587044   http://www.accessdata.fda.gov/drugsatfda_docs/label/2011/020762s044lbl.pdf 1/25/2011
AP01/19/2011SE127596044   http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/020762s044ltr.pdf 1/25/2011
AP011/16/2012SCM       
AP04/18/2014SCM46644049   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/020762Orig1s049.pdf 7/27/2016
AP010/27/2014SCM46645050   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/020762Orig1s050.pdf 7/27/2016
AP03/3/2015SCM46646051   http://www.accessdata.fda.gov/drugsatfda_docs/nda/2015/020762Orig1s051.pdf 7/27/2016




Back to FDA Applications sponsored by MERCK SHARP DOHME